Interleukin-1 and the immunogenetics of Alzheimer disease

J Neuropathol Exp Neurol. 2000 Jun;59(6):471-6. doi: 10.1093/jnen/59.6.471.


Established genetic causes of familial Alzheimer disease (AD) involve genes for beta-amyloid precursor protein (betaAPP), presenilin-1, and presenilin-2. For the more common sporadic forms of AD, increased risk has been associated with a number of genes; the most important of which is the epsilon4 allele of apolipoprotein E. Two recent studies, one clinical and one using postmortem material, now show increased risk for AD associated with certain polymorphisms in the genes encoding the alpha and beta isoforms of interleukin-1 (IL-1). IL-1 levels are elevated in Alzheimer brain, and overexpression of IL-1 is associated with beta-amyloid plaque progression. IL-1 interacts with the gene products of several other known or suspected genetic risk factors for AD, including betaAPP, apolipoprotein E, alpha1-antichymotrypsin, and alpha2-macroglobulin. IL-1 overexpression is also associated with environmental risk factors for AD, including normal aging and head trauma. These observations suggest an important pathogenic role for IL-1, and for IL-1-driven cascades, in the pathogenesis of AD.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / etiology
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / immunology*
  • Alzheimer Disease / physiopathology
  • Genetic Predisposition to Disease*
  • Humans
  • Immunogenetics
  • Interleukin-1 / genetics*
  • Interleukin-1 / physiology
  • Polymorphism, Genetic / physiology
  • Risk Factors


  • Interleukin-1